Rare infiltrative lung diseases: A challenge for clinicians

Respiration

Volumn 71, Issue 5, 2004, Pages 431-443

  Poletti, Venerino ^a,b   Costabel, Ulrich ^c   Casoni, Gian Luca ^a   Bigliazzi, Caterina ^a   Drent, Marjolein ^d   Olivieri, Dario ^b  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c RUHRLANDKLINIK   (Germany)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute eosinophilic pneumonia; Alveolar proteinosis; Inherited lipidoses; Pulmonary amyloidosis; Rare diffuse infiltrative lung diseases

Indexed keywords

BETA GLUCOSIDASE; CHELATING AGENT; CORTICOSTEROID; GLYCOLIPID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MIGLUSTAT; PIRFENIDONE; SPHINGOMYELIN;

AGE DISTRIBUTION; AMYLOIDOSIS; BONE MARROW TRANSPLANTATION; CHEMICAL ANALYSIS; DIAGNOSTIC PROCEDURE; ELECTRON MICROSCOPY; FABRY DISEASE; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPOXEMIA; IRRADIATION; LIPIDOSIS; LOEFFLER PNEUMONIA; LUNG ALVEOLAR MICROLITHIASIS; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG CALCIFICATION; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TRANSPLANTATION; MICROSCOPY; NIEMANN PICK DISEASE; NONHUMAN; OCULAR ALBINISM; PARENCHYMAL AMYLOIDOSIS; PERIODIC ACID SCHIFF STAIN; PREVALENCE; PRIORITY JOURNAL; REMISSION; RESPIRATORY TRACT AMYLOIDOSIS; REVIEW; SEX RATIO; STONE FORMATION; THORAX PAIN; TRACHEOBRONCHIAL AMYLOIDOSIS;

ACUTE DISEASE; AMYLOIDOSIS; HERMANSKI-PUDLAK SYNDROME; HUMANS; LIPIDOSES; LITHIASIS; LUNG DISEASES; OSSIFICATION, HETEROTOPIC; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY ALVEOLI; PULMONARY EOSINOPHILIA; RARE DISEASES;

EID: 5644285273     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080625     Document Type: Review

References (104)

1. Zompatori M, Bnà C, Poletti V, Spaggiari E, Ormitti F, Calabrò E, Tognini G, Sverzellati N: Diagnostic imaging of diffuse infiltrative disease of the lung. Respiration 2004;71:4-19.
2. Chetta A, Marangio E, Olivieri D: Pulmonary function testing in interstitial lung diseases. Respiration 2004;71:209-213.
3. Poletti V, Chilosi M, Olivieri D: Diagnostic invasive procedures in diffuse infiltrative lung diseases. Respiration 2004;71:107-119.
4. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P: Interstitial lung disease induced by drugs and radiation. Respiration 2004;71:301-326.
5. Rosen SH, Castleman B, Liebow AA: Pulmonary alveolar proteinosis. N Engl J Med 1958;258:1123-1142.
6. Costello JF, Moriarty DC, Branthwaite MA, Turner-Warwick M, Corrin B: Diagnosis and management of alveolar proteinosis: The role of electron microscopy. Thorax 1975;30:121-132.
7. Maygarden SJ, Iacocca MV, Funkhouser WK, Novotny DB: Pulmonary alveolar proteinosis: A spectrum of cytologic, histochemical, and ultrastructural findings in bronchoalveolar lavage fluid. Diagn Cytopathol 2001;24:389-395.
8. Prakash UB, Barham SS, Carpenter HA, Dines DE, Marsh MH: Pulmonary alveolar phospholipoproteinosis: Experience with 34 cases and a review. Mayo Clin Proc 1987;62:499-518.
9. Alberti A, Luisetti M, Braschi A, Rodi G, Lotti G, Sella D, Poletti V, Benori V, Baritussio A: Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. Am J Respir Crit Care Med 1996;154:817-820.
10. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S: Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152:1860-1866.
11. Honda Y, Takahashi H, Shijubo N, Kuroki Y, Akino T: Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 1993;103:496-499.
12. Trapnell BC, Whitsett JA, Nakata K: Pulmonary alveolar proteinosis. N Engl J Med 2003;349:2527-2539.
13. Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, Jobe AH, Whitsett JA: Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 1999;276:L556-L563.
14. Huffman JA, Hull WM, Dranoff G, Mulligan RC, Whitsett JA: Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest 1996;97:649-655.
15. Nishinakamura R, Wiler R, Dirksen U, Morikawa Y, Arai K, Miyajima A, Burdach S, Murray R: The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation. J Exp Med 1996;183:2657-2662.
16. Dirksen U, Nishinakamura R, Groneck P, Hattenhorst U, Nogee L, Murray R, Burdach S: Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest 1997;100:2211-2217.
17. Bewig B, Wang XD, Kirsten D, Dalhoff K, Schafer H: GM-CSF and GM-CSF beta c receptor in adult patients with pulmonary alveolar proteinosis. Eur Respir J 2000;15:350-357.
18. Kitamura T, Tanaka N, Watanabe J, et al: Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colonystimulating factor. J Exp Med 1999;190:875-880.
19. Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ: Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 2002;27:481-486.
20. Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK: Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;161:1143-1148.
21. Seymour JF, Presneill JJ, Schoch OD, et al: Therapeutic efficacy of ganulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001;163:524-531.
22. Costabel U, Corrin B: Alveolar proteinosis; in Gibson GJ, Geddes DM, Costabel U, Sterk PJ, Corrin B (eds): Respiratory Medicine, ed 3. London, Saunders, 2003, pp 1676-1682.
23. Du Bois RM, McAllister WA, Branthwaite MA: Alveolar proteinosis: Diagnosis and treatment over a 10-year period. Thorax 1983;38:360-363.
24. Kariman K, Kylstra JA, Spock A: Pulmonary alveolar proteinosis: Prospective clinical experience in 23 patients for 15 years. Lung 1984;162:223-231.
25. Seymour JF, Presneill JJ: Pulmonary alveolar proteinosis: Progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215-235.
26. Lee KN, Levin DL, Webb WR, Chen D, Storto ML, Golden JA: Pulmonary alveolar proteinosis: High-resolution CT, chest radiographic, and functional correlations. Chest 1997;111:989-995.
27. Kitamura T, Uchida K, Tanaka N, Tsuchiya T, Watanabe J, Yamada Y, Hanaoka K, Seymour JF, Schoch OD, Doyle I, Inoue Y, Sakatani M, Kudoh S, Azuma A, Nukiwa T, Tomita T, Katagiri M, Fujita A, Kurashima A, Kanegasaki S, Nakata K: Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;162:658-662.
28. Pattle RE: Properties, function and origin of the alveolar lining layer. Nature 1955;175:1125-1126.
29. Rogers RM, Levin DC, Gray BA, Moseley LW Jr: Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978;118:255-264.
30. Robertson HE: Pulmonary alveolar proteinosis. Can Med Assoc J 1965;93:980-983.
31. Smith LJ, Katzenstein AL, Ankin MG, Shapiro BA: Management of pulmonary alveolar proteinosis: Clinical conference in pulmonary disease from Northwest University McGaw Medical Center, Chicago. Chest 1980;78:765-770.
32. Kao D, Wasserman K, Costley D, Benfield JR: Advances in the treatment of pulmonary alveolar proteinosis. Am Rev Respir Dis 1975;111:361-363.
33. Miller A, Brown LK, Pastores GM, Desnick RJ: Pulmonary involvement in type 1 Gaucher disease: Functional and exercise findings in patients with and without clinical interstitial lung disease. Clin Genet 2003;63:368-376.
34. Santamaria F, Parenti G, Guidi G, Filocamo M, Strisciuglio P, Grillo G, Farina V, Sarnelli P, Rizzolo MG, Rotondo A, Andria G: Pulmonary manifestations of Gaucher disease: An increased risk for L444P homozygotes? Am J Respir Crit Care Med 1998;157:985-989.
35. Mistry PK, Sirrs S, Chan A, Pritzker MR, Duffy TP, Grace ME, Meeker DP, Goldman ME: Pulmonary hypertension in type 1 Gaucher's disease: Genetic and epigenetic determinants of phenotype and response to therapy. Mol Genet Metab 2002;77:91-98.
36. Zimran A, Elstein D: Gaucher disease and the clinical experience with substrate reduction therapy. Philos Trans R Soc Lond B Biol Sci 2003;358:961-966.
37. Gonzalez-Reimers E, Sanchez-Perez MJ, Bonilla-Arjona A, Rodriguez-Gaspar M, Carrasco-Juan JL, Alvarez-Arguelles H, Santolaria-Fernandez F: Case report. Pulmonary involvement in an adult male affected by type B Niemann-Pick disease. Br J Radiol 2003;76:838-840.
38. Millat G, Chikh K, Naureckiene S, Sleat DE, Fensom AH, Higaki K, Elleder M, Lobel P, Vanier MT: Niemann-Pick disease type C: Spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. Am J Hum Genet 2001;69:1013-1021.
39. Brown LK, Miller A, Bhuptani A, Sloane MF, Zimmerman MI, Schilero G, Eng CM, Desnick RJ: Pulmonary involvement in Fabry disease. Am J Respir Crit Care Med 1997;155:1004-1010.
40. Kelly MM, Leigh R, McKenzie R, Kamada D, Ramsdale EH, Hargreave FE: Induced sputum examination: Diagnosis of pulmonary involvement in Fabry's disease. Thorax 2000;55:720-721.
41. Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR: Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138:338-346.
42. Huizing M, Boissy RE, Gahl WA: Hermansky-Pudlak syndrome: Vesicle formation from yeast to man. Pigment Cell Res 2002;15:405-419.
43. Witkop CJ, Nunez Babcock M, Rao GH, Gaudier F, Summers CG, Shanahan F, Harmon KR, Townsend D, Sedano HO, King RA, et al: Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med PR 1990;82:333-339.
44. Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, Duffy LF, Kuehl EM, Troendle J, Bernardini I: Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med 1998;338:1258-1264.
45. Huizing M, Helip-Wooley A, Dorward H, Claassen D, Hess R, Gahl WA: IL-25 Hermansky-Pudlak syndrome: A model for abnormal vesicle formation and trafficking. Pigment Cell Res 2003;16:584.
46. Di Pietro SM, Falcon-Perez JM, Dell'Angelica EC: Characterization of BLOC-2, a complex containing the Hermansky-Pudlak syndrome proteins HPS3, HPS5 and HPS6. Traffic 2004;5:276-283.
47. Avila NA, Brantly M, Premkumar A, Huizing M, Dwyer A, Gahl WA: Hermansky-Pudlak syndrome: Radiography and CT of the chest compared with pulmonary function tests and genetic studies. AJR Am J Roentgenol 2002;179:887-892.
48. Nakatani Y, Nakamura N, Sano J, et al: Interstitial pneumonia in Hermansky-Pudlak syndrome: Significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type II pneumocytes. Virchows Arch 2000;437:304-313.
49. Gahl WA, Brantly M, Troendle J, et al: Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab 2002;76;234-242.
50. Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN: Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore) 1996;75:334.
51. Shintani H, Fujimura M, Yasui M, Ueda K, Kameda S, Noto M, Matsuda T, Kobayashi M: Acute eosinophilic pneumonia caused by cigarette smoking. Intern Med 2000;39/1:66-68.
52. Philit F, Etienne-Mastroianni B, Parrot A, Guerin C, Robert D, Cordier JF: Idiopathic acute eosinophilic pneumonia: A study of 22 patients. Am J Respir Crit Care Med 2002;166:1235-1239.
53. Trisolini R, Cancellieri A, Bonaccorsi A, Poletti V: Bronchoalveolar lavage suggesting diffuse alveolar damage in a patient with acute eosinophilic pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:311-312.
54. Utz JP, Swensen SJ, Gertz MA: Pulmonary amyloidosis: The Mayo Clinic experience from 1980-1993. Ann Intern Med 1996;124:407-413.
55. Thompson PJ, Citron KM: Amyloid and the lower respiratory tract. Thorax 1983;38:84-87.
56. Smith RR, Hutchins GM, Moore GW, et al: Type and distribution of pulmonary parenchymal and vascular amyloid. Am J Med 1979;66:96-104.
57. Hui AN, Koss MH, Hochholzer L, Wehunt WD: Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical and histochemical studies on 48 cases. Arch Pathol Lab Med 1986;110:212-218.
58. Fukumura M, Mieno T, Suzuki T, et al: Primary diffuse tracheobronchial amyloidosis treated by bronchoscopic Nd-YAG laser irradiation. Jpn J Med 1990;29:620-622.
59. Schulz C, Hauck RW, Nathrath WB, et al: Combined amyloidosis of the upper and lower respiratory tract. Respiration 1995;62:163-166.
60. Troxler RF, Kane K, Berg AM, et al: Localised amyloidosis of the larynx: Evidence for light chain composition. Ann Otol Rhinol Laryngol 1993;102:884-889.
61. Toyoda M, Ebihara Y, Kato H, et al: Tracheobronchial AL amyloidosis: Histological, immunohistochemical, ultrastructural and immunoelectron microscopic observations. Hum Pathol 1993;24:970-976.
62. Himmelfarb E, Wells S, Rabinowitz JG: The radiologic spectrum of cardiopulmonary amyloidosis. Chest 1977;72:327-332.
63. Rubinow A, Celli BR, Cohen AS, et al: Localised amyloidosis of the lower respiratory tract. Am Rev Respir Dis 1978;118:603-611.
64. Ayuso MC, Gilabert R, Bombi JA, et al: CT appearance of localised pulmonary amyloidosis. J Comput Assist Tomogr 1987;11:197-199.
65. Gillmore JD, Hawkins PH: Amyloidosis and the respiratory tract. Thorax 1999;54:444-451.
66. Pickford HA, Swensen SJ, Utz GP: Thoracic cross-sectional imaging of amyloidosis. AJR Am J Roentgenol 1997;168:351-355.
67. Ohdama S, Akagawa S, Matsubara O, Yoshizawa Y: Primary diffuse alveolar septal amyloidosis with multiple cysts and calcification. Eur Respir J 1996;7:1569-1571.
68. Celli R, Rubinow A, Cohen AS, et al: Patterns of pulmonary involvement in systemic amyloidosis. Chest 1978;74:543-547.
69. Desai RA, Mahajan VK, Benjamin S, et al: Pulmonary amyloidoma and hilar adenopathy. Chest 1979;76:170-173.
70. Khan JA, Shamsi SH, Rana TA, et al: Pulmonary amyloidosis: A case with hilar and mediastinal involvement and review of the literature. Clin Pulm Med 1996;2:66-69.
71. Gallego FG, Canelas JC: Hilar enlargement in amyloidosis. N Engl J Med 1974;291:531.
72. Puchtler H, Sweat F, Levine M: On the binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355-364.
73. Tan SY, Pepys MB: Amyloidosis. Histopathology 1994;25:403-414.
74. Hawkins PN, Myers MJ, Lavender JP, Pepys MB: Diagnostic radionuclide imaging of amyloid: Biological targeting by circulating human serum amyloid P component. Lancet 1988;i:1413-1418.
75. Kung J, Zhuang H, Yu JQ, Duarte PS, Alavi A: Intense fluorodeoxyglucose activity in pulmonary amyloidosis on positron emission tomography. Clin Nucl Med 2003;12:975-976.
76. Gertz MA, Lacy MQ, Dispenzieri A: Immunoglobulin light-chain amyloidosis - Primary amyloidosis; in Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B (eds): Wintrobe's Clinical Hematology, ed 11. Philadelphia, Lippincott Williams & Wilkins, 2004, pp 2637-2665.
77. Buja LM, Roberts WC: Pulmonary parenchymal ossific nodules in idiopathic hypertrophic subaortic stenosis. Am J Cardiol 1970;25:710-715.
78. Popelka CG, Kleinerman J: Diffuse pulmonary ossification. Arch Intern Med 1977;137:523-525.
79. Ndimbie OK, Williams CR, Lee MW: Dendriform pulmonary ossification. Arch Pathol Lab Med 1987;111:1062-1064.
80. Galloway R, Epstein EJ, Coulshed N: Pulmonary ossific nodules in mitral valve disease. Br Heart J 1961;23:297-307.
81. Whitaker W, Black A, Warrack AJN: Pulmonary ossification in patients with mitral stenosis. J Fac Radiol 1955;7:29-34.
82. Azuma A, Miyamoto H, Enomoto T, Usuki J, Kudoh S: Familial clustering of dendriform pulmonary ossification. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:152-154.
83. Joines RW, Roggli VL: Dendriform pulmonary ossification: Report of two cases with unique findings. Am J Clin Pathol 1989;91:398-402.
84. Rajjoub S, Altmeyer RB: A case report of idiopathic pulmonary ossification. WV Med J 1998; 94: 143-145.
85. Gevenois PA, Abehsera M, Knoop C, Jacobovitz D, Estenne M: Disseminated pulmonary ossification in end-stage pulmonary fibrosis: CT demonstration. AJR Am J Roentgenol 1994;162:1303-1304.
86. Kim SW, Charter RA, Chai CJ, Kim SK, Kim ES: Serum alkaline phosphatase and inorganic phosphorus values in spinal cord injury patients with heterotopic ossification. Paraplegia 1990;28:441-447.
87. Green JD, Harle TS, Greenberg SD, Weg JG, Nevin H, Jenkins DE: Disseminated pulmonary ossification. Am Rev Respir Dis 1970;101:293-298.
88. Schwarz MI, King TE: Interstitial Lung Disease, ed 3. Hamilton, Decker, 1998.
89. Maiti SK, Singh GR: Bone morphogenic proteins: Novel regulators of bone formation. Indian J Exp Biol 1998;36:237-244.
90. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA, Loyd JE, Nichols WC, Trembath RC: Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 2000;26:81-84.
91. Muramatsu T, Hamano H, Fukumashi K, Shiigai T, Fujiseki M, Katayanagi T, Osada K, Inoue T, Shimono M: An experimental study of chondrogenesis and osteogenesis in rat submandibular gland induced by implantation of demineralized dentin. Bull Tokyo Dent Coll 1993;34:15-22.
92. Mahy PR, Ursit MR: Experimental heterotopic bone formation induced by bone morphogenetic protein and recombinant human interleukin-1B. Clin Orthop 1988;237:236-244.
93. Akagawa KS, Takasuka N, Nozaki Y, Komuro I, Azuma M, Ueda M, Naito M, Takahashi K: Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multi-nucleated giant cells from human monocytes. Blood 1996;88:4029-4039.
94. Barnard NJ, Crocker PR, Blainey AD, Davies RJ, Ell SR, Levison DA: Pulmonary alveolar microlithiasis: A new analytical approach. Histopathology 1987;11:639-645.
95. Castellana G, Lamorgese V: Pulmonary alveolar microlithiasis. Respiration 2003;70:549-555.
96. Coetzee T: Pulmonary alveolar microlithiasis with involvement of the sympathetic nervous system and gonads. Thorax 1970;25:637-642.
97. Sosman MC, Dodd GD, Jones WD, Pillmore GU: The familial occurrence of pulmonary alveolar microlithiasis. AJR Am J Roentgenol 1957;77:947-1012.
98. Ucan ES, Keyf AI, Aydilek R, Yalcin Z, Sebit S, Kudu M, Ok U: Pulmonary alveolar microlithiasis: Review of Turkish reports. Thorax 1993;48:171-173.
99. Bogart SD: Disseminated pulmonary calcinosis with pulmonary alveolar microlithiasis. NY State J Med 1980;80:1283-1284.
100. Cluzel P, Grenier P, Bernadac P, Laurent F, Picard JD: Pulmonary alveolar microlithiasis: CT findings. J Comput Assist Tomogr 1991;15:938-942.
101. Chai JL, Patz EF: CT of the lung: Patterns of calcification and other high-attenuation abnormalities. AJR Am J Roentgenol 1994;162:1063-1066.
102. Gocmen A, Toppare MF, Kiper N, Buyukpamukcu N: Treatment of pulmonary alveolar microlithiasis with a diphosphonate: Preliminary results of a case. Respiration 1992;59:250-252.
103. Richardson J, Slovis B, Miller G, Dummer S: Development of pulmonary alveolar microlithiasis in a renal transplant recipient. Transplantation 1995;59:1056-1057.
104. Freiberg DB, Young IH, Laks L, Regnis JA, Lehrhaft B, Sullivan CE: Improvement in gas exchange with nasal continuous positive airway pressure in pulmonary alveolar microlithiasis. Am Rev Respir Dis 1992;145:1215-1216.